Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04821869 · ClinicalTrials.gov registry record
ProAir Digihaler in COPD Disease Management: A Real World Study
A clinical trial, sponsored by Pulmonary Research Institute of Southeast Michigan.
- Completed
- Registry status
- 27
- Enrollment target
NCT04821869 is a clinical trial that has completed, run by Pulmonary Research Institute of Southeast Michigan. The registered enrollment target is 27 participants.
The verdict
NCT04821869 has completed, sponsored by Pulmonary Research Institute of Southeast Michigan.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
A pilot study to explore the utilization of the TEVA ProAir Digihaler rescue medication use and inhalation parameters to identify disease deterioration to help in the management of COPD patients in clinical practice. The study is designed to follow a small sample size of patients with COPD, monitor and collect inhalation parameters from the Digihaler dashboard, and changes in symptom control as measured by the COPD Assessment Test (CAT) to identify potential inhalation parameter thresholds that could be applied to the management of patients with COPD in clinical practice.
Interventions
- DRUG ProAir Digihaler
- DEVICE Digihaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-05-10 |
| Est. Completion | 2022-06-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04821869
The ClinicalTrials.gov registry entry for NCT04821869 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pulmonary Research Institute of Southeast Michigan, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ProAir Digihaler is the first listed.
NCT04821869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04821869 about?
NCT04821869 is a clinical study titled "ProAir Digihaler in COPD Disease Management: A Real World Study". A pilot study to explore the utilization of the TEVA ProAir Digihaler rescue medication use and inhalation parameters to identify disease deterioration to help in the management of COPD patients in clinical practice. The study is designed to follow a small sample size of patients with COPD, monitor ...
What is the current status of trial NCT04821869?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2021-05-10. Estimated completion is 2022-06-21.
What interventions are being tested in trial NCT04821869?
The interventions under investigation include: ProAir Digihaler (DRUG), Digihaler (DEVICE).
Who is sponsoring clinical trial NCT04821869?
This trial is sponsored by Pulmonary Research Institute of Southeast Michigan, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.